OPKO Health, Inc. Business Acquisition, Pro Forma Net Income (Loss)
OPKO Health, Inc. (OPK) reported Business Acquisition, Pro Forma Net Income (Loss) of -$50.01 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2015-02-27
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-09-30 was -$50.01M.
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-06-30 was -$26.08M.
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2013-12-31 was -$277.66M.
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2013-09-30 was -$75.86M.
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2013 was -$147.55M.
- OPKO Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2012 was -$55.66M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$50.01M 10-Q · filed 2014-11-07 | -$76.09M derived: sum of 2 quarters · filed 2014-11-07 | -$121.18M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$26.08M 10-Q · filed 2014-08-11 | -$71.16M 10-Q · filed 2014-08-11 | ||
| 2013-12-31 | -$277.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$353.52M derived: sum of 2 quarters · filed 2015-02-27 | -$367.76M derived: sum of 3 quarters · filed 2015-02-27 | -$147.55M 10-K · filed 2015-02-27 |
| 2013-09-30 | -$75.86M 10-Q · filed 2014-11-07 | -$90.10M derived: sum of 2 quarters · filed 2014-11-07 | $130.12M 10-Q · filed 2014-11-07 | -$143.27M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$14.24M 10-Q · filed 2014-08-11 | -$51.81M 10-Q · filed 2014-08-11 | -$67.42M derived: sum of 3 quarters · filed 2015-02-27 | -$83.16M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$41.38M 10-Q · filed 2014-05-09 | -$53.18M derived: sum of 2 quarters · filed 2015-02-27 | -$68.92M derived: sum of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | -$11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$27.54M derived: sum of 2 quarters · filed 2015-02-27 | -$55.66M 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$15.74M 10-Q · filed 2013-11-12 | -$43.86M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |